Alcohol Use Not Tied to Sustained Virologic Response With Hepatitis C Treatment
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 29, 2023 -- Alcohol use is not associated with lower odds of sustained virologic response (SVR) among patients initiating direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection, according to a study published online Sept. 26 in JAMA Network Open.
Emily J. Cartwright, M.D., from the Atlanta Veterans Affairs Medical Center, and colleagues evaluated whether alcohol use at DAA treatment initiation is associated with a decreased likelihood of SVR. The analysis included 69,229 patients with chronic HCV infection who initiated DAA therapy between Jan. 1, 2014, and June 30, 2018.
The researchers found that 94.4 percent of patients achieved SVR. Overall, 46.6 percent of participants were abstinent without alcohol use disorder (AUD), 13.3 percent were abstinent with AUD, 19.4 percent had lower-risk consumption, 4.5 percent had moderate-risk consumption, and 16.2 percent had high-risk consumption or AUD. There was no difference in SVR across alcohol use categories, even for patients with high-risk consumption or AUD when adjusting for other confounders (odds ratio, 0.95; 95 percent confidence interval, 0.85 to 1.07). Furthermore, there was no interaction by stage of hepatic fibrosis measured by fibrosis-4 score.
"These findings suggest that restricting access to DAA therapy on the basis of alcohol use creates an unnecessary barrier for patients and challenges HCV elimination goals," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Considerable Gaps Seen in Provision of Effective Treatment for Opioid Addiction
TUESDAY, July 16, 2024 -- There are considerable gaps in provision of effective treatments for opioid use disorders (OUD) at U.S. substance use disorder (SUD) treatment...
For the First Time Since the Pandemic, Pedestrian Death Rates Fall in the U.S.
TUESDAY, June 25, 2024 -- A total of 7,318 American pedestrians were killed by motor vehicles in 2023 -- a dip of 5.4 percent from 2022 and the first such decline seen since the...
Alcohol Use Tied to Mood Instability in Patients With Bipolar Disorder
FRIDAY, June 7, 2024 -- Alcohol use is associated with mood instability (depression and manic symptoms) in people with bipolar disorder (BD), according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.